Heartbeat Labs

Heartbeat Labs is a Berlin-based venture capital firm established in 2017 that focuses on seed and early-stage investments in the healthcare sector, particularly in digital health, life sciences, and digital pharmaceuticals. The firm collaborates with agile teams comprising entrepreneurs, medical specialists, and technology experts to launch multiple digital health companies each year. Heartbeat Labs provides seed funding ranging from €0.5 to €5 million, along with access to a distinctive network of investors and operational support in areas such as marketing, human resources, finance, and regulatory affairs. With a track record of building over 20 successful internet companies, Heartbeat Labs aims to harness digitization to enhance the healthcare industry in Germany.

Johannes Keienburg

Managing Director

Krawinkel, Hendrik

Co-Founder and Managing Director

11 past transactions

Betriebsarzt Service

Series A in 2022
Betriebsarzt Service offer you an uncomplicated, high-quality and reliable occupational health and safety-related care adapted to the needs of your employees and your company. They specialize in companies in growth and consolidation phases as well as industries that are subject to rapid change. Acute needs, such as the examination of electrical equipment, medical check-ups and all other occupational health and safety services, you can book with us individually!

CureSkin

Series A in 2022
CureSkin is a Bengaluru-based company founded in 2016 that specializes in AI-powered mobile applications for dermatological care. The app utilizes computer vision technology to analyze user-uploaded photos, identifying various skin issues such as acne, dark spots, scars, and pigmentation. Based on the analysis, CureSkin recommends personalized treatment plans, skincare products, and connects users with dermatologists for follow-up consultations. By offering these services, CureSkin aims to provide accessible and effective skin health solutions, particularly for individuals who may not have easy access to trained professionals.

Farmako

Seed Round in 2018
Farmako GmbH is a research-based pharmaceutical company and distributor of medical cannabis, founded in 2018 and headquartered in Frankfurt, Germany, with an additional office in London, United Kingdom. The company focuses on developing alternative medicines utilizing cannabis formulations, positioning itself as a provider of natural remedies. Farmako aims to become a vertically integrated leader in the European medical cannabis market, operating in countries with established legal frameworks for this industry. It places a strong emphasis on innovation through research and development, striving to enhance the therapeutic options available to doctors, patients, and pharmacists. Additionally, Farmako is involved in conducting medical trials to further validate the efficacy of cannabinoid therapies.

BetterDoc

Venture Round in 2018
BetterDoc is Germany's market leader for medical expert referrals. BetterDoc is generating, processing and analyzing all types of quality data of a health care system. These data are used to identify the best medical expert for the patient's individual health problem. BetterDoc is also measuring for each patient case the outcome quality ("full quality loop").

Nebula Genomics

Series A in 2018
Nebula Genomics is a company that focuses on human genome sequencing and health data, aiming to create a comprehensive online marketplace for genomic information. Founded in 2016 by Harvard genomics pioneer George Church and his colleagues, the company is headquartered in San Francisco, California, with additional offices in Boston, Massachusetts. Nebula Genomics utilizes blockchain technology to empower consumers by allowing them to maintain control over their genomic data and receive compensation for its use. The platform aggregates extensive genetic information, enabling researchers to analyze data for accelerated drug development and personalized medicine. The company’s DNA sequencing technology covers all genes, regulatory regions, the Y chromosome, and mitochondrial DNA, facilitating in-depth genetic analysis and variant exploration.

Caresyntax

Venture Round in 2018
Caresyntax Inc. is a Boston-based company that provides a digital surgery platform designed to enhance surgical performance and improve patient outcomes. The platform integrates various data sources, including video, audio, and clinical information, to deliver actionable insights for operating room (OR) teams. By leveraging advanced analytics and IoT technology, Caresyntax enables healthcare organizations to benchmark surgical outcomes, optimize resource utilization, and reduce variability in clinical performance. The software is utilized in over 4,000 operating rooms globally, supporting more than 30,000 surgeons and impacting the care of over 2 million patients each year. The company offers solutions that facilitate real-time reporting and workflow automation, allowing hospitals to mitigate risks and improve surgical training without the extensive investment typical of traditional big data analytics. Founded in 1991, Caresyntax continues to advance the use of technology in healthcare to drive better surgical practices and outcomes.

Medlanes

Series A in 2018
Medlanes is an online medical consultation service that enables users to connect with doctors from anywhere at any time. Through its app, patients can request medical advice and organize home visits from healthcare professionals. The service primarily caters to private patients and self-payers, offering an affordable way to access medical guidance. By collaborating with emergency doctors, Medlanes facilitates timely and convenient healthcare solutions, ensuring that patients receive the support they need without unnecessary delays.

Mimi Hearing Technologies

Series A in 2018
Mimi Hearing Technologies GmbH, founded in 2014 and based in Berlin, Germany, specializes in hearing enhancement technology and software for smartphones. The company is recognized for its Mimi.io application, which enables users to conduct hearing tests, explore various hearing enhancement profiles, and understand the challenges associated with hearing loss. As a leader in digital hearing tests and sound personalization, Mimi has achieved over one million app downloads across 150 countries, creating the largest database of digital hearing profiles globally. Its proprietary technology, Mimi Defined™, optimizes individual hearing experiences and can be integrated into a wide range of audio products, including headphones, TVs, smartphones, and streaming services. Mimi's innovative offerings have garnered multiple prestigious awards, highlighting its commitment to advancing hearing technology and improving the auditory experience for users.

Daatrics

Seed Round in 2017
Daatrics is a technology company focused on providing innovative monitoring solutions for caregivers and families. The company offers the Neebo product line, which consists of small, multifunctional wearable devices designed to continuously monitor a child's vital activities. These devices track essential parameters such as sound, thermal comfort, heart rate, and blood oxygen levels in real time, ensuring that parents and caregivers are informed about their child's status, even when close supervision is not possible. Notably, Daatrics' devices operate without emitting chronic electromagnetic radiation, prioritizing the health and safety of children.

CureSkin

Seed Round in 2017
CureSkin is a Bengaluru-based company founded in 2016 that specializes in AI-powered mobile applications for dermatological care. The app utilizes computer vision technology to analyze user-uploaded photos, identifying various skin issues such as acne, dark spots, scars, and pigmentation. Based on the analysis, CureSkin recommends personalized treatment plans, skincare products, and connects users with dermatologists for follow-up consultations. By offering these services, CureSkin aims to provide accessible and effective skin health solutions, particularly for individuals who may not have easy access to trained professionals.

Moodpath

Venture Round in 2016
You’re going through a difficult phase in life and are worried about your mental health? Moodpath is a leading depression app and accompanies you on your way out of depression. Moodpath screens your well-being by asking questions on a daily basis. The screening makes you more conscious about your thoughts, feelings and emotions. After two weeks, you receive an electronic doctor letter. This letter will make your conversation with a professional much easier. More than 150 psychological exercises and videos give you a better understanding of your moodpath and strengthen your mental health.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.